Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011.

Slides:



Advertisements
Similar presentations
1 Survey Data in ECA : Frequency, Coverage, Consistency and Access By Victor Sulla ECS-PE.
Advertisements

European Union The Gay Perspective SCOREBOARD V 2.0.
Directive 95/50/EC TDG Checks Application of Annexes Erkki Laakso EUROPEAN COMMISSION DG ENERGY & TRANSPORT TDG Checks Riga June 2006.
Erasmus+ International Credit Mobility Call for Proposals 2016
Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.
CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.
Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
Progress of European integration
  Surveillance Data reported by Case definition used characteristics
Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014
Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.
Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
DISTRIBUTION AUTOMATIC - GENERATION
Country Cases Rate National data Report type
Table 1. Reported invasive Haemophilus influenzae cases: number and rate per population, EU/EEA, 2010–2014 Country Con­firmed.
Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014
Country Cases Rate National data Report type
Table. Ebola and Marburg fevers, surveillance systems overview, 2014
Table 1. Criteria for differentiating acute and chronic hepatitis B
Table 1. Cases of reported, confirmed cases of invasive pneumococcal disease: number and rate per population, EU/EEA, 2010–2014 Country
Country Cases Rate National data Report type
Cases Rate National data Report type
Table. Yellow fever, surveillance systems overview, 2014
Table 1. Reported, confirmed campylobacteriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes,
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country
Table 1. Reported confirmed brucellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
The European Parliament – voice of the people
The European Parliament – voice of the people
ESF FINANCIAL EXECUTION PART 1 STATE OF PLAY END 2016
Country Cases Rate National data Report type
Gonorrhoea cases of gonorrhoea were reported by 27 EU/EEA Member States for The overall notification rate was 18.8 cases per 100 000 population.
Table 1. Criteria for differentiating acute and chronic hepatitis C
Transmission, processing and publication of the HBS 2015 data
Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2011–2015 Country
EU: First- & Second-Generation Immigrants
Table 1. Number of reported confirmed LGV cases, EU/EEA, 2010–2014
MSFD Scoreboard Status at 23 November 2012 Belgium Bulgaria Cyprus
Table 1. Table 1. Reported confirmed salmonellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Country Cases Rate National data Report type
Table 1. Number and rate of reported confirmed gonorrhoea cases per population, EU/EEA, 2010–2014 Country Cases Rate Austria.
Table 1. Reported confirmed VTEC infection cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.
Table 1. Reported confirmed cholera cases, EU/EEA, 2010–2014
Table 1. Number and rate of reported confirmed chlamydia cases per population, EU/EEA, 2010–2014 Country Cases Rate Austria.
Table 1. Reported confirmed botulism cases: number and rate per population, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
ESF FINANCIAL EXECUTION ESF Technical Working Group Meeting June 2018
Country Cases Rate National data Report type
Country Cases Rate National data Report type
Table 1. Reported confirmed leptospirosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.
European Union Membership
Table. Plague, surveillance systems overview, 2014
Chlamydia In 2016, cases of chlamydia infection were reported in 26 EU/EEA Member States. The overall notification rate was 184 per 100 000 persons.
Country Cases Rate Austria   Belgium Bulgaria
Overall 2011 ESF Budget Execution
ESF FINANCIAL EXECUTION ESF Technical Working Group Meeting June 2018
Table 1. Locally acquired cases of West Nile fever: number and rate per population, EU/EEA, 2010–2014 Country Cases Rate.
Table 1. Confirmed cases of trichinellosis: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N = no,
ESF FINANCIAL EXECUTION ESF Technical Working Group Meeting June 2018
Country Cases Rate National data Report type
Source: Country reports
Trends for ECDC measles and rubella monitoring,
Country Cases Rate National data Report type
Marine Strategy Framework Directive: Status of reporting
Table 1. Reported confirmed listeriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Table 1. Table 1. Reported confirmed toxoplasmosis cases: number and rate per live births, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Source: Country reports
Table 1. Reported confirmed yersiniosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Presentation transcript:

Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011 2012 2013 2014 Cases Rate National data Report type Reported cases Confirmed cases ASR Austria 85 1.0 49 0.6 56 0.7 Y C 37 35 0.4 Belgium 96 0.9 111 123 1.1 134 1.2 87 0.8 Bulgaria 8 0.1 13 0.2 12 A 15 Croatia . 41 26 33 Cyprus 1 6 2 4 0.5 Czech Republic 60 63 59 42 Denmark 66 72 1.3 55 45 Estonia 7 3 Finland 34 20 21 France 511 563 550 575 426 420 Germany 386 369 354 345 275 273 0.3 Greece 52 Hungary 67 51 47 Iceland Ireland 98 2.2 89 1.9 77 1.7 78 76 Italy 150 152 135 162 156 Latvia 5 9 Liechtenstein Lithuania 48 1.5 1.4 53 1.8 2.6 71 Luxembourg Malta 2.8 19 3.1 Netherlands 143 106 110 108 83 Norway 39 24 27 18 Poland 228 282 238 250 188 187 Portugal 79 69 61 Romania 68 70 Slovakia 31 29 23 Slovenia 11 Spain 404 431 335 262 198 146 Sweden 103 74 United Kingdom 1008 1.6 1036 862 852 758 750 EU/EEA 3713 3835 3513 3448 2873 2760 Source: Country reports. Legend: Y = yes, N = no, C = case based, · = no report, ASR: age-standardised rate Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 1. Reported, confirmed cases of invasive meningococcal disease, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 2. Number of cases of reported, confirmed invasive meningococcal disease per 100 000 population, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 3. Cases of reported, confirmed invasive meningococcal disease, by age and gender, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 4. Seasonal distribution of cases of reported, confirmed invasive meningococcal disease, EU/EEA, 2014 compared with 2010−2013 Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 5. Trend and number of cases of reported, confirmed invasive meningococcal disease, EU/EEA, 2010−2014 Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 6. Trend of confirmed cases of invasive meningococcal disease by serogroup, EU/EEA, 2010−2014 Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 7. Serogroup distribution of confirmed cases of invasive meningococcal disease by age group, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 8. Trend and number of cases of reported, confirmed invasive meningococcal disease, EU/EEA, 2010−2014 Contributing countries without MCC vaccination policy: Czech Republic, Denmark, Estonia, Finland, Hungary, Latvia, Lithuania, Malta, Norway, Poland, Romania, Slovakia, Slovenia, Sweden. Contributing countries with MCC vaccination policy: Austria, Belgium, Cyprus, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Portugal, Spain, United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Table. Invasive meningococcal disease, surveillance systems overview, 2014   Surveillance Data reported by Case definition used characteristics Country Data source L P H O Austria AT-Epidemiegesetz Cp Co C Y EU-2008 Belgium BE-REFLAB V Se A N Not specified/unknown Bulgaria BG-NATIONAL_SURVEILLANCE Croatia HR-CNIPH EU-2012 Cyprus CY-NOTIFIED_DISEASES Czech Republic CZ-MENI-NRL Denmark DK-LAB Estonia EE-NAKIS Finland FI-NIDR Other France FR-MANDATORY_INFECTIOUS_DISEASES Germany DE-SURVNET@RKI-7.1/6 Greece EL-NOTIFIABLE_DISEASES Hungary HU-EFRIR Iceland IS-SUBJECT_TO_REGISTRATION Ireland IE-CIDR Italy IT-MENINGITIS Latvia LV-BSN Lithuania LT-COMMUNICABLE_DISEASES Luxembourg LU-SYSTEM1 EU-2002 Malta MT-DISEASE_SURVEILLANCE Netherlands NL-NRBM Norway NO-MSIS_A Poland PL-NATIONAL_SURVEILLANCE Portugal PT-MENINGOCOCAL Romania RO-RNSSy Slovakia SK-EPIS Slovenia SI-SURVIVAL Spain ES-STATUTORY_DISEASES Sweden SE-SMINET United Kingdom UK-MENINGOCOCCAL Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A) Data reported by: laboratories (L), physicians (P), hospitals (H), other (O) Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2016. Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged